Correlation Between Microsoft and Prostatype Genomics
Can any of the company-specific risk be diversified away by investing in both Microsoft and Prostatype Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Prostatype Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Prostatype Genomics AB, you can compare the effects of market volatilities on Microsoft and Prostatype Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Prostatype Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Prostatype Genomics.
Diversification Opportunities for Microsoft and Prostatype Genomics
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Microsoft and Prostatype is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Prostatype Genomics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prostatype Genomics and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Prostatype Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prostatype Genomics has no effect on the direction of Microsoft i.e., Microsoft and Prostatype Genomics go up and down completely randomly.
Pair Corralation between Microsoft and Prostatype Genomics
Given the investment horizon of 90 days Microsoft is expected to generate 0.11 times more return on investment than Prostatype Genomics. However, Microsoft is 8.99 times less risky than Prostatype Genomics. It trades about 0.01 of its potential returns per unit of risk. Prostatype Genomics AB is currently generating about -0.01 per unit of risk. If you would invest 42,222 in Microsoft on September 3, 2024 and sell it today you would earn a total of 124.00 from holding Microsoft or generate 0.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.4% |
| Values | Daily Returns |
Microsoft vs. Prostatype Genomics AB
Performance |
| Timeline |
| Microsoft |
| Prostatype Genomics |
Microsoft and Prostatype Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Prostatype Genomics
The main advantage of trading using opposite Microsoft and Prostatype Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Prostatype Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prostatype Genomics will offset losses from the drop in Prostatype Genomics' long position.| Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
| Prostatype Genomics vs. Sprint Bioscience AB | Prostatype Genomics vs. Stayble Therapeutics AB | Prostatype Genomics vs. iZafe Group AB | Prostatype Genomics vs. Idogen AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |